ACADIAN ASSET MANAGEMENT LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 1.3%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2023$22
-45.0%
12,192
-44.6%
0.00%
Q4 2022$40
-100.0%
22,025
-36.9%
0.00%
-100.0%
Q2 2022$98,000
-52.0%
34,888
+11.5%
0.00%0.0%
Q3 2021$204,000
+750.0%
31,289
+1417.4%
0.00%
Q3 2020$24,000
-65.2%
2,062
-52.0%
0.00%
Q2 2020$69,0004,2950.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 7,346,829$15,723,00027.32%
TFG Asset Management GP Ltd 3,039,381$6,504,0000.78%
Nantahala Capital Management 5,215,788$11,162,0000.72%
Frazier Life Sciences Management, L.P. 3,746,857$8,018,0000.62%
HARBOR CAPITAL ADVISORS, INC. 148,454$318,0000.29%
DAFNA Capital Management LLC 496,150$1,062,0000.29%
Blackstone Inc. 17,985,611$38,4890.14%
Ikarian Capital, LLC 260,087$556,0000.11%
MYDA Advisors LLC 100,000$214,0000.10%
Privium Fund Management B.V. 113,528$253,0000.09%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders